The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long term observation

Annals of the Rheumatic Diseases

Volumn 56, Issue 11, 1997, Pages 661-666

  Bootsma, Hendrika ^a   Spronk, Peter E ^a   Ter Borg, Evert J ^a   Hummel, Elsje J ^a   De Boer, Greetje ^a   Limburg, Pieter C ^a   Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031441503     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.11.661     Document Type: Article

References (26)

1. Buskila D, Shoenfeld Y. Autoantibodies and antigens. Section III. In: Lahita RG, ed. Systemic lupus erythematosus. 2nd ed. New York; Churchill Livingstone, 1992: 203-343.
2. Tan EM. Autoantibodies to nuclear antigens: their immunobiology and medicine. Adv Immunol 1982;33:167-240.
3. Aotsuka S, Okawa M, Ikebe K, Yokohari R. Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes. J Immunol Methods 1979;28:149-62.
4. Hylkema MN, Huygen H, Kramers C, et al. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods 1994;170:93 102.
5. Hahn BH, Tsao BP. Antibodies to DNA. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. Los Angeles: Lea & Febger, 1993: 195 201.
6. Esdaile JM, Abrahamowicz M, Joseph L, MacKenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Arthritis Rheum 1996;39:370-8.
7. Borg EJ, ter Horst G, Hummel EJ, Limburg PC, Kallenberg CGM. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990;33: 634-43.
8. Bootsma H, Spronk PE, Derksen RHWM, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345:1595-9.
9. Brinkman K, Brink H, van der, Swaak AJG. A comparison of assays used for the detection of antibodies to DNA. Clin Rheumatol 1990;9 (suppl 1):63 73.
10. Swaak AJG, Smeenk RJT. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985;44:245-51.
11. Tax WJM, Kramers C, Bruggen MCJ, van, Berden JHM. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 1995;48:666 73.
12. Rothfield NF, Stollar BD. The relation of Ig class, pattern of ANA and complement-fixing antibodies to DNA in sera from patients with SLE. J Clin Invest 1967;46:1785-94
13. Krippner H, Merle S, Jürgens K, Pirlet K. Antibodies to dsDNA and ssDNA in the immunoglobulin classes IgG and IgM: prognostic value in the course of SLE. Z Rheumatol 1984;43:265-71.
14. Pennebaker JB, Gilliam JN, Ziff M. Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest 1977;60:1331 8.
15. Isenberg DA, Dudeney C, Williams W, et al. Measurement of anti-dsDNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 1987;46:448 56.
16. Werle E, Blazek M, Fiehn W. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescece test. Lupus 1992;1:369 77.
17. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. Arthritis Rheum 1991;34:937-44.
18. Sontheimer RD, Gilliam JN. DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis. Clin Immunol Immunopathol 1978;10:459-67.
19. Miniter MF, Stollar BD, Agnello V. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 1979;22:959-68.
20. Swaak AJG, Groenwold J, Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986;45:359-66.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271 5.
22. Feltkamp TEW. Standards for ANA and anti-DNA. Clin Rheumatol 1990;9 (suppl 1):74-81.
23. Clough JD, Valenzuela R. Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA. Am J Med 1980;68:80-5.
24. Okamura M, Kanyama Y, Amastu K, et al. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis 1993;52:14 20.
25. Talal N. Disordered immunologic regulation and autoimmunity. Transplant Rev 1976;31:240 63.
26. Namboodiri MS, Nagpal S, Subha Rao PV, Induction of anti-DNA IgG and IgE antibodies in BALB/c mice. J Autoimmun 1992;5:653 63.